News

Ligustrazine phosphate injection is used intravenously in hospital for treating ischemic cerebrovascular disease, such as insufficiency of blood-supply, cerebral thrombosis as well as cerebral embolism. Juan Han, chairman

The trial is a randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of Epliga for the adjunctive treatment of refractory partial onset seizures in patients with

The Phase IIb trial is designed to assess the effect of Kai-9803 on reducing myocardial injury in patients with ST segment elevation myocardial infarction (STEMI) who are undergoing

This agreement is a result of the previously announced intention to close Devgen’s pharma division. This closure will lead to the employment of the 19 employees, active in

As per the terms of the settlement, Lupin will be licensed under the relevant desloratadine patents, and free to commercially launch its generic desloratadine product, on July 1,

Mr Campbell is a manager and senior analyst for Dorset Management and a member of Knott Partners Management. Mr Campbell holds a BS degree from McGill University. Mr

Cellumen’s cardiac hypertrophy panel is designed to simultaneously measure eight distinct toxicity indicators in drug compounds including mitochondrial function, oxidative stress, apoptosis, and cellular hypertrophy. By leveraging Cellumen’s

Study ADX10059-204 is a double-blind, placebo-controlled, multi-center European Phase IIb trial in about 90 gastroesophageal reflux disease (GERD) patients known to respond well to proton pump inhibitors (PPI).

This collaboration will allow the development of highly-targeted commercial information products and continuing medical education (CME) programs for physicians, based on aggregated, HIPAA-compliant patient information derived from individual